Cleared Traditional

K091486 - K-ASSAY MICROALBUMIN AND K-ASSAY MICROA...

K091486 is the FDA 510(k) clearance for K-ASSAY MICROALBUMIN AND K-ASSAY MICROA... by Kamiya Biomedical Co.. It is a Class 2 Chemistry device (product code DCF) cleared through the Traditional 510(k) pathway after a 345-day FDA review.

K091486 · Kamiya Biomedical Co. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2010
Decision
345d
Days
Class 2
Risk

K091486 is an FDA 510(k) clearance for the K-ASSAY MICROALBUMIN AND K-ASSAY MICROALBUMIN CALIBRATOR. Classified as Albumin, Antigen, Antiserum, Control (product code DCF), Class II - Special Controls.

Submitted by Kamiya Biomedical Co. (Tukwila, US). The FDA issued a Cleared decision on April 29, 2010 after a review of 345 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 866.5040 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Kamiya Biomedical Co. devices

Submission Details

510(k) Number K091486 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 19, 2009
Decision Date April 29, 2010
Days to Decision 345 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
257d slower than avg
Panel avg: 88d · This submission: 345d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DCF Albumin, Antigen, Antiserum, Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5040
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - DCF Albumin, Antigen, Antiserum, Control

All 27
Devices cleared under the same product code (DCF) and FDA review panel - the closest regulatory comparables to K091486.
EASYRA MICRO-ALBUMIN REAGENT AND CALIBRATOR
K101089 · Medica Corp. · Jul 2011
TINA-QUANT ALBUMIN GEN 2
K101203 · Roche Diagnostics · Sep 2010
COBAS 8000 MODULAR SERIES ANALYZER
K100853 · Roche Diagnostics Corp. · Sep 2010
SYNCHRON SYSTEMS MICROALBUMIN (MA) REAGENT, MODEL 475100
K082251 · Beckman Coulter, Inc. · Apr 2009
DIMENSION VISTA MICROALBUMIN FLEX REAGENT CARTRIDGE
K061990 · Dade Behring, Inc. · Sep 2006
DCL MICROALBUMIN ASSAY, MODEL 252-20
K051191 · Diagnostic Chemicals , Ltd. · Jul 2005